Navigation Links
Industry Veterans Join Molecular Imprints' Management Team
Date:7/1/2008

hnology and the growing market opportunities ahead of us," said Mark Melliar-Smith, CEO of Molecular Imprints. "Their arrival falls on the heels of two important milestones which also serve to highlight our growing momentum. Just over a month ago, we introduced the industry's only high-speed, double-sided pilot-production-ready nanopatterning system for patterned media applications. On the semiconductor side of the business we recently announced a sale of our new Imprio 300 system to SEMATECH, a consortium of leading semiconductor manufacturers. Our customers will benefit from their technical and market experience and knowledge."

Before joining Molecular Imprints, Eynon was the director of advanced lithography process development for Samsung and the associate director of lithography for SEMATECH. His industry experience also includes management positions at KLA-Tencor, Photronics, DuPont Photomasks and Texas Instruments. Hofemann previously held vice president-level roles in marketing and business development at Photronics, ADE and Veeco Instruments -- where he worked on HDD and emerging applications. Hofemann also held management positions at KLA-Tencor, Semi-Gas Systems and Applied Materials.

About Molecular Imprints, Inc.

Molecular Imprints, Inc. (MII) is the technology leader for high- resolution, low cost-of-ownership nanopatterning systems and solutions in the hard disk drive (HDD) and semiconductor industries. MII is leveraging its innovative Step and Flash Imprint Lithography (S-FIL(R)) with Drop-on- Demand(TM) material application technology to become the worldwide market and technology leader in high-volume patterning solutions for storage and memory devices, while enabling emerging markets in optics, biotechnology, and other industries. MII enables nanoscale patterning by delivering a comprehensive nanopatterning solution that is affordable, compatible and extendible to sub- 10-nanometer resolution levels. For more information, visit
'/>"/>

SOURCE Molecular Imprints, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
2. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
3. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
4. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
5. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
6. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
7. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
8. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
9. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
10. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
11. Suntech to Attend Upcoming Investor Conferences and Industry Events

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... 5 GenVec, Inc. (Nasdaq:... the third quarter ended September 30, 2009. GenVe...hare) for the three months ended September 30, 200...r share) in the comparable quarter of 2008. For th...et loss was $14.1 million ($0.15 per share), compa...
(Date:11/5/2009)... Nov. 5 ThermoGenesis Co...tive products for processing and storing adult ste...ter of fiscal 2010. ,, For the quarter ended Se... $5.2 million, a 15 percent increase over revenues...The Company said the key contributors to the growt...
(Date:11/5/2009)... 5 Cepheid (Nasdaq: CPH...eaking at the following investor conferences, and ... Credit Suisse Healthcare Conferenc...ber, 2009 at 10 a.m. Mountain Time, ...nd, Tuesday, 1 December, 2009 at 1...
(Date:11/5/2009)...PRNewswire/ -- SpineSmith Partners has signed an i... a unique scaffold that mimics the structure of na...veral commercial products by SpineSmith,s Research...the GenOsteo scaffold represents a significant adv...deal environment for the delivery of adult stem ce...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...ology To Potentially Improve ...7 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) toda...arch and License Agreement with Genentech, Inc. ex...ional targets for potential improvement,of product...nger,DNA-binding protein nuclease (ZFN) technology...
...Group,(Debiopharm), a global independent biopharma...s medical conditions and particularly oncology, to...cology chair at the Ecole,Polytechnique Federale d...,in Oncogenesis. Funded through a CHF 2.5 million ...ge the wide scope of ideas and inventions,discover...
...generate antibodies against novel resea...rmany and ST. LOUIS, Feb. 27 ,Sigma-Aldrich(TM) (N...xchange: MOR; Prime Standard Segment, TecDAX) toda...roduce and distribute unique,recombinant research ...D(R),technology. MorphoSys,s AbD Serotec unit will...
Other Biology Technology:Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production 2Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production 3Debiopharm and EPFL Establish an Oncology Chair 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 3
(Date:11/6/2009)...FAIRFAX, Va.Registration is now open for the Socie...erventional Oncology (IO) Therapies" Webinar, whic...and transcatheter treatment of liver tumors, kidne... national organization of physicians, scientists a...ing public health through pioneering advances in i...
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hills, ...(LEID) will be installing its locker system and pa...BACS) at the U.S. Department of Health and Human S... in Bethesda, MD. The locker system will support ...for protecting our nation,s medical research agenc...
(Date:11/5/2009)...New Haven, Conn.Researchers at Yale University hav...ng the body,s immune response to HIV and HIV-infec...eir findings, published online in the Journal of ...l therapeutic approaches for these diseases. , ...e targeting HIV" (ARM-H) and "antibody-recruiting ...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 1Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 2Mirixa Corporation Announces Key Pharmacy Network Hire 5339 1Mirixa Corporation Announces Key Pharmacy Network Hire 5339 2Newly Updated Pharmacy State Law Compendium Available 5335 1Newly Updated Pharmacy State Law Compendium Available 5335 2
... NYU Langone Medical Center scientists and their ... La Jolla, Calif., have discovered an unexpected c...l meningitis, an infection of the central nervous ...nal Nature. The finding may lead to a new way of t... to viral diseases. , The NYU researchers, Michae...
...adly form of malaria for humans, Plasmodium falci...nzees, this group has been fairly isolated on the ...analysis from the Sackler Institute for Comparativ...ry reveals that malarial parasites found in tree-d...ip with P. falciparum and Plasmodium reichenowi...
...tains, from the Apennines to the Alps, have fascin... Walter Alvarez for more than 35 years, resulting ... that traces Italy,s billion-year geologic history...ndbreaking - and often overlooked - discoveries. ,...n & Company, Inc. Alvarez, a UC Berkeley professor...
Other Biology News:Peering inside the skull of a mouse to solve meningitis mystery 2Peering inside the skull of a mouse to solve meningitis mystery 3African thicket rat malaria linked to virulent human form 2Italy's geologic history becomes a personal tale in Walter Alvarez's new book 2Italy's geologic history becomes a personal tale in Walter Alvarez's new book 3Italy's geologic history becomes a personal tale in Walter Alvarez's new book 4
... identified as the cellular homolog of the avian s...been shown to be almost identical to c-Jun in thei...zation and DNA binding, whereas their N-terminal d...vation, diverge. Antigen: The antibody was pro...
Mouse Anti-Yersinia pestis Capsular F1 Antigen Monoclonal Antibody, Unconjugated, Clone YBF19 from QED Bioscience Inc.
Rabbit Anti-JMJD2D Polyclonal Antibody, Unconjugated from Abcam
Perm/Wash Buffer from BD Biosciences Pharmingen
Biology Products: